Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - CHAMPIONS ONCOLOGY, INC. | c13732e10vq.htm |
EX-32.1 - EXHIBIT 32.1 - CHAMPIONS ONCOLOGY, INC. | c13732exv32w1.htm |
EX-99.1 - EXHIBIT 99.1 - CHAMPIONS ONCOLOGY, INC. | c13732exv99w1.htm |
EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
Section 302 Certification
Section 302 Certification
I, Joel Ackerman, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of
Champions Biotechnology, Inc., a Delaware corporation; |
|
2. | Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in
light of the circumstances under which such statements
were made, not misleading with respect to the period
covered by this report; |
|
3. | Based on my knowledge, the financial statements, and
other financial information included in this report,
fairly present in all material respects the financial
condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report; |
|
4. | The registrants other certifying officer(s) and I are
responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and
procedures, or caused such disclosure
controls and procedures to be designed
under our supervision, to ensure that
material information relating to the
registrant, including its consolidated
subsidiaries, is made known to us by
others within those entities,
particularly during the period in which
this report is being prepared; |
||
(b) | Designed such internal control over
financial reporting, or caused such
internal control over financial reporting
to be designed under our supervision, to
provide reasonable assurance regarding
the reliability of financial reporting
and the preparation of financial
statements for external purposes in
accordance with generally accepted
accounting principles; |
||
(c) | Evaluated the effectiveness of the
registrants disclosure controls and
procedures and presented in this report
our conclusions about the effectiveness
of the disclosure controls and
procedures, as of the end of the period
covered by this report based on such
evaluation; and |
||
(d) | Disclosed in this report any change in
the registrants internal control over
financial reporting that occurred during
the Registrants most recent fiscal
quarter (the Registrants fourth fiscal
quarter in the case of an annual report)
that has materially affected, or is
reasonably likely to materially affect,
the Registrants internal control over
financial reporting; and |
5. | The registrants other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
Registrants board of directors (or persons performing the equivalent
functions): |
(a) | All significant deficiencies and material
weaknesses in the design or operation of
internal control over financial reporting
which are reasonably likely to adversely
affect the registrants ability to
record, process, summarize and report
financial information; and |
||
(b) | Any fraud, whether or not material, that
involves management or other employees
who have a significant role in the
registrants internal control over
financial reporting |
Date: March 7, 2011 | /s/ Joel Ackerman | |||
Joel Ackerman | ||||
Chief Executive Officer (Principal Executive Officer and Acting Principal Financial Officer) |